iodoazomycin arabinoside has been researched along with galactose in 2 studies
| Studies (iodoazomycin arabinoside) | Trials (iodoazomycin arabinoside) | Recent Studies (post-2010) (iodoazomycin arabinoside) | Studies (galactose) | Trials (galactose) | Recent Studies (post-2010) (galactose) |
|---|---|---|---|---|---|
| 27 | 1 | 6 | 18,988 | 193 | 4,605 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, P; Narain, R; Quan, S; Wang, Y; Zhou, A | 1 |
| Diaz-Dussan, D; Kumar, P; Macdonald, D; Narain, R; Peng, YY; Rashed, FB; Weinfeld, M | 1 |
2 other study(ies) available for iodoazomycin arabinoside and galactose
| Article | Year |
|---|---|
Galactose-based Thermosensitive Nanogels for Targeted Drug Delivery of Iodoazomycin Arabinofuranoside (IAZA) for Theranostic Management of Hypoxic Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Galactose; HeLa Cells; Hep G2 Cells; Humans; Liver Neoplasms; MCF-7 Cells; Nanogels; Nitroimidazoles; Polyethylene Glycols; Polyethyleneimine; Radiation-Sensitizing Agents; Temperature; Theranostic Nanomedicine | 2015 |
Optimized Carbohydrate-Based Nanogel Formulation to Sensitize Hypoxic Tumors.
Topics: Animals; Cell Hypoxia; Cell Line, Tumor; Galactose; Humans; Hypoxia; Male; Mice; Nanogels; Prostatic Neoplasms | 2023 |